ArticleJournal of thoracic disease2018
Osimertinib therapy as first-line treatment before acquiring T790M mutation: from AURA1 trial.
Kentaro Ito et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it